Home » Topics » BioWorld Science

BioWorld Science
RSS

As nanoparticles, vitamins fight sepsis

Jan. 15, 2020

New targets, new booster for CAR-T cells

Jan. 15, 2020

Lilly opens enrollment in phase I study of CD73 inhibitor LY-3475070 in advanced cancer

Jan. 14, 2020

Neos studies NT-0502 in pilot phase I trial for chronic sialorrhea

Jan. 14, 2020

Abeona initiates phase III study of EB-101 in recessive dystrophic epidermolysis bullosa

Jan. 14, 2020

FDA approves Valtoco as acute treatment for seizures

Jan. 14, 2020

FDA clears IND for phase Ib/II study of AVB-500 in clear cell renal cell carcinoma

Jan. 14, 2020

Zhejiang Vimgreen Pharma discloses adenosine A2A receptor antagonists

Jan. 14, 2020

New cardiac sarcomere inhibitors discovered at Cytokinetics

Jan. 14, 2020

MSD KK receives approval for Pifeltro for treating HIV-1 infection

Jan. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...